Right DirectionThe findings follow data this summer that showed half of those treated with Amgen’s drug at a wide range of doses responded. The latest results more than doubled the number of patients treated with the highest dose and tracked them for three more months. It’s too early to know how long the benefits will last and … Continue reading Channing Der Quoted by Bloomberg
September 4, 2019 Congratulations to Kirsten Bryant, Ph.D., for her acceptance of the Joseph S. Pagano Award! This award recognizes outstanding work by the Lineberger’s postdoctoral research associates. We are proud of Kirsten's accomplishments. Read more about Kirsten's award ceremony.
Congratulations to Irem Dagliyan for successfully passing her doctoral defense! Irem presented Low dose vertical inhibition of ERK MAPK cascade for the treatment of KRAS-mutant cancer in 4007 Genetic Medicine Building. Afterword, she celebrated her success with her labmates, friends, and family. We are excited for Irem to begin her new journey as Dr. Irem Dagliyan! … Continue reading Congratulations, Dr. Irem Dagliyan!
Kirsten Bryant, Ph.D., was one of three to be selected through a competitive process for this honor, which comes with a $2,500 award. The three recipients will be formally recognized in the ceremony and Kirsten will present. The Pagano Awards are named for Joseph Pagano, MD, UNC Lineberger director emeritus and Lineberger Professor of Cancer Research. … Continue reading Kirsten Bryant to Present at Pagano Award Ceremony
August 5, 2019 Today, the Der and Cox labs were visited by the Blue Ribbon group of Wilmington, NC. The Blue Ribbon Run raises money for the Julie M. Brown and Christina M. Gianoplus Fund for Colon Cancer Research from Wilmington, NC. Members of the group included Ana Boudreau, event founder, and Sarah Powell, a … Continue reading Der Lab Blue Ribbon Tour 2019
Kirsten Bryant, Ph.D., Research Assistant Professor in the Department of Pharmacology, was recently awarded a Developmental Research Project grant from the Washington University SPORE in Pancreatic Cancer. Congratulations, Kirsten!
Nate Diehl was awarded an NCI F30 Individual Predoctoral MD/Ph.D. fellowship entitled “Validation of WEE1 kinase as a clinical target in KRAS-mutant pancreatic cancer”. Jenny Klomp, Ph.D., was awarded an NCI F32 Individual Postdoctoral fellowship entitled “Defining the roles of the ERK MAPK in driving KRAS-mutant pancreatic cancer growth”. Congratulations to you both!
July 13th, 2019 The Der and Cox labs met at Channing's home to wish lab members, Kat Lambert, Devon Blake, and Richard Hodge, well in their future careers. Kat was accepted to UNC-Chapel Hill for graduate school. Richard completed his post-doctoral fellowship and returned to England. Devon accepted a position at Ribometrix as a scientist. … Continue reading Lab Member Farewell Party
Channing Der is an expert in the field of so-called RAS genes, which play an important role regarding the control of cancer cell growth. The oncologist, who holds a professorship at the University of Carolina in Chapel Hill, continues his research at the Institute of Pathology at Charité-Universitätsmedizin Berlin. The aim of Der's research project … Continue reading Einstein BIH Visiting Fellow: Channing Der
This year lab members Antje Schaefer and Andrew Waters presented at the FASEB: Regulation and Function of Small GTPases Conference in Olean, New York. Antje's presentation, pictured below, was on "The gain-of-function mutation Y42C in RHOA promotes FAK activation and dependency in diffuse gastric cancer."